Perioperative Bacterial Infections in Deceased Donor and Living Donor Liver Transplant Recipients

Journal of Clinical and Experimental Hepatology

Volumn 2 1, Issue 1, 2012, Pages 35-41

  Varghese, Joy ^a   Gomathy, Narasimhan ^a   Rajashekhar, Perumalla ^a   Venugopal, Kota ^a   Olithselvan, Arikichenin ^a   Vivekanandan, Shanmugam ^a   Naresh, Shanmugam ^a   Sujatha, Chandrasekaran ^b   Vijaya, Srinivasan ^a   Jayanthi, Venkataraman ^a   Rela, Mohamed ^a  

^a Global Hospitals and Health City   (India)

^b NONE   (India)

Author keywords

Bacteria; Infection; Liver transplant

Indexed keywords

ALBUMIN; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL BLEEDING; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLINICAL ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DECEASED DONOR; DONOR; ESCHERICHIA COLI; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATIC ARTERY THROMBOSIS; HIGH RISK PATIENT; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; INTESTINE PERFORATION; KLEBSIELLA; LENGTH OF STAY; LIVER GRAFT; LIVING DONOR; MALE; NONHUMAN; OPERATION DURATION; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; RETROSPECTIVE STUDY; TREATMENT DURATION; TUBERCULOSIS; URINARY TRACT INFECTION;

EID: 84859877193     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/S0973-6883(12)60081-4     Document Type: Article

References (26)

1. Jha V, Chugh KS Post transplant infections in the tropical countries. Artif Organs 2002, 26:770-777.
2. George B, Mathews V, Srivastawa A, Chandy M Infections among allogeniec bone marrow recipients in India. Bone Marrow Transplant 2004, 33:311-315.
3. Fishman JA Infection in solid organ transplant recipients. NEJM 2007, 357:2601-2614.
4. Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994, 170:644-652.
5. Castalo P, Stratta RJ, Wood RP, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991, 126:149-156.
6. Gladdy RA, Richardson SE, Davies SE, et al. Candida infection in pediatric liver transplant recipients. Liver Transpl Surg 1999, 5:16-24.
7. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988, 67:132-143.
8. Kanj SS, Sharara AI, Calvien PA, et al. Cytomegalic virus infection following liver transplantation: review of literature. Clin Infect Dis 1996, 22:537-549.
9. Principles and Procedures for Blood cultures-Approved guidelines. Clinical Laboratory Standards Institute, January 2007. Doc.M47.
10. Torbenson M, Wang J, Nichols L, et al. Causes of death in autopsied liver transplantation patients. Mod Pathol 1998, 11:37-46.
11. Winston DJ, Emmanouilides C, Busuttil RW Infections in liver transplant recipients. Clin Infect Dis 1995, 21:1077-1089.
12. Colona JO, Winston DJ, Brill JE, et al. Infectious complications in liver transplantation. Arch Surg 1988, 123:360-364.
13. Kim YJ, Kim SI, Wie SH Infectious complications in living donor liver transplant recipients: 9-year single center experience. Transpl Infect Dis 2008, 10:316-324.
14. Singh N, Wagner MM, Gayowski T Seasonal pattern of early mortality and infectious complications in liver transplant recipients. Liver Transpl 2001, 7:884-889.
15. Fishman JA, Rubin RH Infection in organ-transplant recipients. NEJM 1998, 338:1741-1751.
16. Singh N, Wagener MM, Obaman A, et al. Bacteremias in liver transplant recipients: shift toward gram negative bacteria as predominant pathogens. Liver Transpl 2004, 10:844-849.
17. Hashimoto A, Hashimoto M, Sugawara Y, et al. Bloodstream infection after living donor liver transplantation. Scand J Infect Dis 2008, 40:509-516.
18. Hashimoto M, Sugawara Y, Tamura S, et al. Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective cohort study. BMC Infect Dis 2008, 11:155. (Abstract).
19. Hashimoto A, Hashimoto M, Sugawars Y, et al. Impact of new methicillin-resistant Staphylococcus aureus carriage postoperatively after living donor liver transplantation. Transplant Proc 2007, 39:3271-3275.
20. Kim BS, Lee SG, Hwang S, et al. Influence of pretransplantation bacterial and fungal culture positivity on outcome after living donor liver transplantation. Transplant Proc 2009, 41:250-252.
21. Kim YJ, Yoon JH, Kim SI, et al. High mortality associated with acinetobacter species infection in liver transplant patients. Transplant Proc 2011, 43:2397-2399.
22. Holty JE, Gould MK, Meinke L, et al. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009, 15:894-906.
23. Jahng AW, Tran T, Bui L, et al. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during candidacy period. Transplantation 2007, 83:1557-1562.
24. Subramanian N, Dorman S, AST Infectious Disease Community of Practice Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S57-S62.
25. Singh N, Wagener MM, Gayowski T Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of post-transplant tuberculosis. Transplantation 2002, 74:892-895.
26. Chan AC, Lo CM, Ng KK, et al. Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation. Liver Int 2007, 27:81-85.